Quantcast

Gel formulations containing insecticide

Imported: 25 Feb '17 | Published: 10 Sep '02

Dietmar Kalder, Rolf Jung, Burkhard Mielke

USPTO - Utility Patents

Abstract

The present invention relates to novel insecticidal gel formulations for the controlled and sustained release of insecticidally active compounds by means of a heat source.

Claims

1. A gel formulation useful in the controlled and sustained release of a vapor containing at least one insecticidally active compound comprising:

wherein said vaporization modifier is present in an amount sufficient to modify the vaporization rate of said gel formulation at an operating temperature from about 70° C. to about 110° C.; and wherein said gel formulation forms said vapor containing at least one pyrethroid upon heating to said operating temperature, whereby surfaces exposed to said vapor remain substantially free of residues of said vaporization modifier during use of said gel formulation.

2. The gel formulation of claim 1, wherein said vaporization modifier is selected from the group consisting of Guerbet alcohols having CAS No. 67187-86-0or CAS No. 36311-34-9, and combinations and mixtures thereof.

3. The gel formulation of claim 1, wherein said pyrethroid is prallethrin.

4. The gel formulation of claim 1, wherein said pyrethrin is 3-allyl-2-methyleyelopent-2-en-4-on-1-yl D-cis/trans-chrysanthemate.

5. The gel formulation of claim 1, wherein said pyrethrin is 1-ethinyl-2-methyl-2-pentenyl 2,2 dimethyl-3-(2-methyl-1-propenyl)-cyclopropane-carboxylate.

6. The gel formulation of claim 1, wherein said at least one insecticidally active compound comprises a natural pyrethrum.

7. The gel formulation of claim 1, wherein said pyrethroid comprises from about 5.0% to about 80% by weight of said gel formulation.

8. The gel formulation of claim 7, wherein said pyrethroid comprises from about 20% to about 50% by weight of said gel formulation.

9. The gel formulation of claim 1, wherein said vaporization modifier comprises from about 40% by weight to about 80% by weight of the formulation.

10. The gel formulation of claim 1, wherein said gel former comprises from about 6% by weight to about 10% by weight of the formulation.

11. The gel formulation of claim 1, wherein the ratio of the total weight of said pyrethroid in said gel formulation to the total weight of said vaporization modifiers is from about 9 to about 0.1.

12. The gel formulation of claim 11, wherein said ratio is from about 2.0 to 0.2.

13. The gel formulation of claim 1, wherein said pyrethroid comprises transfluthrin.

14. The gel formulation of claim 1 further comprising a container for holding said gel formulation during heating to a temperature from about 70° C. to about 110° C.

15. The gel formulation of claim 14, further comprising a heating device adapted to heat said gel formulation in said container to said temperature.